Efficacy of Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (12 to 75 y) (BY9010/M1-142)
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to compare the efficacy of ciclesonide versus fluticasone propionate
on lung function, time to first asthma exacerbation, asthma symptoms, use of rescue
medication, and quality of life in patients with mild to moderate asthma. Ciclesonide will be
inhaled at one dose level once daily; fluticasone propionate will be inhaled at one dose
level twice daily. The study duration consists of a baseline period (2 to 4 weeks) and a
treatment period (24 weeks). The study will provide further data on safety and tolerability
of ciclesonide.